FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

421366001: Dispersible tablet (qualifier value)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2616695019 Tablet for oral suspension en Synonym Active Entire term case insensitive SNOMED CT core module
3562687018 Tablet for conventional release oral suspension en Synonym Active Entire term case insensitive SNOMED CT core module
3562688011 Tablet for conventional release oral suspension (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3636010015 Dispersible oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
2308921000001114 Dispersible tablet (qualifier value) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom Edition module
106634401000001114 Dispersible tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dispersible tablet Is a Tablet false Inferred relationship Existential restriction modifier
Dispersible tablet Is a Oral dose form true Inferred relationship Existential restriction modifier
Dispersible tablet Has dose form administration method Swallow true Inferred relationship Existential restriction modifier
Dispersible tablet Has dose form transformation Disperse true Inferred relationship Existential restriction modifier
Dispersible tablet Has dose form intended site Oral true Inferred relationship Existential restriction modifier
Dispersible tablet Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Dispersible tablet Has basic dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Amoxycillin trihydrate 200mg tablet disperdose for oral suspension Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely deferasirox 500 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely deferasirox 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Amoxycillin trihydrate 400mg tablet disperdose for oral suspension Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely deferasirox 125 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Amoxicillin 600mg tablet for oral suspension Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Amoxicillin trihydrate 200mg tablet for oral suspension Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Amoxicillin trihydrate 400mg tablet for oral suspension Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug) Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely olanzapine 5 milligram/1 each conventional release orodispersible tablet (clinical drug) Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely olanzapine 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Co-codamol 8mg/500mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Aspirin + codeine 400mg/8mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Aspirin+papaveretum 500mg/7.71mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely lamotrigine 25 milligram/1 each conventional release orodispersible tablet (clinical drug) Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely lamotrigine 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Amoxicillin + clavulanate potassium 250mg/125mg s/f dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Doxycycline 100mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Co-trimoxazole 80mg/400mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Co-trimoxazole 160mg/800mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Aspirin 300mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Diclofenac sodium 50mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely aspirin 500 milligram and glycine 133 milligram/1 each conventional release orodispersible tablet (clinical drug) Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Nabumetone 500mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Aspirin + codeine 500mg/8mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely olanzapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug) Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Carglutamic acid 200mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Acyclovir 800mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Acyclovir 200mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Acyclovir 400mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Piroxicam 10mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Piroxicam 20mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Methadone hydrochloride 40mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Lamotrigine 200mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Lamotrigine 50mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Lamotrigine 2mg tablet for conventional release oral suspension Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Lamotrigine 5mg tablet for conventional release oral suspension Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Amoxicillin + clavulanate potassium 250mg/125mg tablet for conventional release oral suspension Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely methadone hydrochloride 40 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely abacavir (as abacavir sulfate) 60 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely deferasirox 400 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely nitazoxanide 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 125 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely deferasirox 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely abacavir (as abacavir sulfate) 120 milligram and lamivudine 60 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely ethionamide 125 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 76.5 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely pyrimethamine 12.5 milligram and sulfadoxine 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely ivermectin 12 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely ethambutol 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely nevirapine 50 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely linezolid 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely ketorolac trometamol 10 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely aciclovir 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely aciclovir 400 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely aciclovir 800 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely levofloxacin 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely cefixime 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely cefalexin 125 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely cefpodoxime (as cefpodoxime proxetil) 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely pyrazinamide 150 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely piroxicam 20 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely cefalexin 500 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely clonazepam 250 microgram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely levocetirizine dihydrochloride 2.5 milligram and montelukast (as montelukast sodium) 4 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely aceclofenac 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely cefixime 100 milligram and ofloxacin 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has manufactured dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug) Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely olanzapine 5 milligram/1 each conventional release orodispersible tablet (clinical drug) Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Aspirin + codeine 400mg/8mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Aspirin 300mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Piroxicam 10mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely lamotrigine 25 milligram/1 each conventional release orodispersible tablet (clinical drug) Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Aspirin+papaveretum 500mg/7.71mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Doxycycline 100mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Acyclovir 400mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely lamotrigine 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely olanzapine 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Acyclovir 800mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Diclofenac sodium 50mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Nabumetone 500mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Piroxicam 20mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Acyclovir 200mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Co-beneldopa 12.5mg/50mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Calcium carbonate 250mg dispersible tablets sugar free Has dispensed dose form True Dispersible tablet Inferred relationship Existential restriction modifier
AaceCa 250mg dispersible tablets (Essential-Healthcare Ltd) Has dispensed dose form True Dispersible tablet Inferred relationship Existential restriction modifier
AaceCa 250mg dispersible tablets (Essential-Healthcare Ltd) 10 tablet Has dispensed dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Calcium carbonate 250mg dispersible tablets sugar free 10 tablet Has dispensed dose form True Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely olanzapine 5 milligram/1 each conventional release orodispersible tablet (clinical drug) Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Nabumetone 500mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Product containing precisely lamotrigine 25 milligram/1 each conventional release orodispersible tablet (clinical drug) Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier
Diclofenac sodium 50mg dispersible tablet Has manufactured dose form False Dispersible tablet Inferred relationship Existential restriction modifier

Page 1 of 17 Next End

This concept is not in any reference sets

Back to Start